References
- Tomiita M, Saito K, Kohno Y, Shimojo N, Fujikawa S, Niimi H. The clinical features of Sjögren's syndrome in Japanese children. Acta Paediatr Jpn 1997;39:268–72.
- Bartunkova J, Sediva A, Venkovsky J, Tesar V. Primary Sjögren's syndrome in children and adolescents: proposal for diagnostic criteria. Clin Exp Ftheumatol 1999;17:381–6.
- Itoh Y, Hamada H, Imai T, Seki T, Igarashi T, Yuge K, et al. Antinuclear antibodies in children with chronic nonspecific com-plaints. Autoimmunity 1997;25:243–50.
- Itoh Y, Fukunaga Y, Igarashi T, Imai T, Yoshida J, Tsuchiya M, et al. Autoimmunity in chronic fatigue syndrome in children. Jpn J Ftheumatol 1998;8:429–37.
- Itoh Y, Igarashi T, Tatsuma N, Imai T, Yoshida J, Tsuchiya M, et al. Immunogenetic background of patients with autoimmune fatigue syndrome. Autoimmunity 2000;32:193–7.
- Hashimoto H, Tsuda H, Matsumoto T, Nasu H, Takasaki Y, Shokawa Y, et al. HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol 1985;12:919–23.
- Itoh Y, Rader MD, Reichlin M. Heterogeneity of the Ro/SSA 14. antigen and autoanti-Ro/SSA response: evidence for 4 antigeni-cally distinct forms. Clin Exp Immunol 1990;81: 45–51.
- Cabral DA, Petty RE, Fung M, Malleson PN. Persistent anti- 15. nuclear antibodies in children without identifiable inflammatory rheumatic or autoimmune disease. Pediatrics 1992;89:441–4.
- Itoh Y. Molecular conformation and autoantibodies to the Ro/SSA 16. particle. Molecular aspects of autoimmunity. In: Homma M, Sugai S, Tojo T, Miyasaka N, Akizuki M, editors. SjOgren's syndrome - 17. state of the art. Amsterdam/New York: Kugler; 1994. p. 131–4.
- Reichlin M, Harley JB. Antibodies to Ro(SSA) and the heteroge-neity of systemic lupus erythematosus. J Rheumato11987;14(Suppl 13):112–7.
- Fox RI, Stem M, Michelson P. Update in SjOgren's syndrome. Curr 18. Opin Ftheumatol 2000;12: 391–8.
- Parke AL. SjOgren's syndrome: a women's health problem. J Ftheumatol 2000;61(Suppl):4–5.19.
- Ben-Chetrit E, Fox RI, Tan EM. Dissociation of immune re-sponses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and SjOgren's syndrome. Arthritis Rheum 1990;33: 349–55.
- Itoh Y. The pathogenesis of neonatal lupus erythematosus and Ro52 (in Japanese). J Jpn Rheum Assoc (Ryumachi) 1996;36:884–90.
- Igarashi T, Itoh Y, Fukunaga Y, Yamamoto M. Stress-induced cell surface expression and antigenic alteration of the Ro/SSA antigen. Autoimmunity 1995;22:33–42.
- Byers DE, Itoh Y, Reichlin M. The evolution of red blood cell and lymphocyte Ro/SSA. Autoimmunity 1990;7:121–8.
- Itoh Y, Itoh K, Frank MB, Reichlin M. Autoantibodies to the Ro/ SSA antigen are conformation-dependent. II. Antibodies to the denatured form of 52 kD Ro/SSA are a cross-reacting subset of antibodies to the native 60 kD Ro/SSA molecule. Autoimmunity 1992;14:89–96.
- Schwab C, Bosshard HR. Caveats for the use of surface-adsorbed protein antigen to test the specificity of antibodies. J Immunol Methods 1992;147:125–34.
- Itoh Y, Reichlin M. Autoantibodies to the Ro/SSA antigen are conformation-dependent. I. Anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein. Autoimmunity 1992;14:57–66.